Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapyJacobson, Jeffrey M ; Felber, Barbara K ; Chen, Huichao ; Pavlakis, George N ; Mullins, James I ; De Rosa, Stephen C ; Kuritzkes, Daniel R ; Tomaras, Georgia D ; Kinslow, Jennifer ; Bao, Yajing ; Olefsky, Maxine ; Rosati, Margherita ; Bear, Jenifer ; Heptinstall, Jack R ; Zhang, Lu ; Sawant, Sheetal ; Hannaman, Drew ; Laird, Gregory M ; Cyktor, Joshua C ; Heath, Sonya L ; Collier, Ann C ; Koletar, Susan L ; Taiwo, Babafemi O ; Tebas, Pablo ; Wohl, David A ; Belaunzaran-Zamudio, Pablo F ; McElrath, M Juliana ; Landay, Alan LAIDS (London), 2024-06, Vol.38 (7), p.963-973 [Periódico revisado por pares]EnglandTexto completo disponível |
|
2 |
Material Type: Artigo
|
In silico designing of novel epitope-based peptide vaccines against HIV-1Heidarnejad, Fatemeh ; Namvar, Ali ; Sadat, Seyed Mehdi ; Pordanjani, Parisa Moradi ; Rezaei, Fatemeh ; Namdari, Haideh ; Arjmand, Sina ; Bolhassani, AzamBiotechnology letters, 2024-06, Vol.46 (3), p.315-354 [Periódico revisado por pares]Dordrecht: Springer NetherlandsTexto completo disponível |
|
3 |
Material Type: Artigo
|
WHO's 2024 global hepatitis reportBurki, TalhaThe Lancet infectious diseases, 2024-06, Vol.24 (6), p.e362-e363 [Periódico revisado por pares]London: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Stabilized trimeric peptide immunogens of the complete HIV-1 gp41 N-heptad repeat and their use as HIV-1 vaccine candidatesWu, Chengwei ; Raheem, Izzat T ; Nahas, Debbie D ; Citron, Michael ; Kim, Peter S ; Montefiori, David C ; Ottinger, Elizabeth A ; Hepler, Robert W ; Hrin, Renee ; Patel, Sangita B ; Soisson, Stephen M ; Joyce, Joseph GProceedings of the National Academy of Sciences - PNAS, 2024-05, Vol.121 (22), p.e2317230121-e2317230121 [Periódico revisado por pares]United StatesTexto completo disponível |
|
5 |
Material Type: Report
|
Meeting of the National Vaccine Advisory CommitteeThe Federal Register / FIND, 2024, Vol.89 (101), p.45664Washington: Federal Information & News Dispatch, LLCTexto completo disponível |
|
6 |
Material Type: Artigo
|
Heterologous prime-boost vaccination drives early maturation of HIV broadly neutralizing antibody precursors in humanized miceCottrell, Christopher A ; Hu, Xiaozhen ; Lee, Jeong Hyun ; Skog, Patrick ; Luo, Sai ; Flynn, Claudia T ; McKenney, Katherine R ; Hurtado, Jonathan ; Kalyuzhniy, Oleksandr ; Liguori, Alessia ; Willis, Jordan R ; Landais, Elise ; Raemisch, Sebastian ; Chen, Xuejun ; Baboo, Sabyasachi ; Himansu, Sunny ; Diedrich, Jolene K ; Duan, Hongying ; Cheng, Cheng ; Schiffner, Torben ; Bader, Daniel L V ; Kulp, Daniel W ; Tingle, Ryan ; Georgeson, Erik ; Eskandarzadeh, Saman ; Alavi, Nushin ; Lu, Danny ; Sincomb, Troy ; Kubitz, Michael ; Mullen, Tina-Marie ; Yates, 3rd, John R ; Paulson, James C ; Mascola, John R ; Alt, Frederick W ; Briney, Bryan ; Sok, Devin ; Schief, William RScience translational medicine, 2024-05, Vol.16 (748), p.eadn0223-eadn0223 [Periódico revisado por pares]United States: The American Association for the Advancement of ScienceTexto completo disponível |
|
7 |
Material Type: Artigo
|
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strainsWang, Shixia ; Chan, Kun-Wei ; Wei, Danlan ; Ma, Xiuwen ; Liu, Shuying ; Hu, Guangnan ; Park, Saeyoung ; Pan, Ruimin ; Gu, Ying ; Nazzari, Alexandra F ; Olia, Adam S ; Xu, Kai ; Lin, Bob C ; Louder, Mark K ; McKee, Krisha ; Doria-Rose, Nicole A ; Montefiori, David ; Seaman, Michael S ; Zhou, Tongqing ; Kwong, Peter D ; Arthos, James ; Kong, Xiang-Peng ; Lu, ShanNature communications, 2024-05, Vol.15 (1), p.4301-4301 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
8 |
Material Type: Newsletter Articles
|
Investigating Viruses in Cells Used to Make Vaccines; and Evaluating the Potential Threat Posed by Transmission of Viruses to HumansAIDS Vaccine Week, 2024, p.656NewsRX LLCTexto completo disponível |
|
9 |
Material Type: Newsletter Articles
|
Supporting the Production of Safe and Effective Influenza VaccinesAIDS Vaccine Week, 2024, p.582NewsRX LLCTexto completo disponível |
|
10 |
Material Type: Newsletter Articles
|
Evaluating New Approaches to Developing AIDS Vaccines by Creating Virus-like Particles that Display HIV Antigens or by Using Live, Attenuated , non-HIV Viruses to Express HIV ProteinsAIDS Vaccine Week, 2024, p.618NewsRX LLCTexto completo disponível |